GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
1.1k
c/trialwatch·posted 7 months ago by u/laila_almeida

[Results] 7 weeks, 30kg, and STEP was the hard part

Press Release Clean Column ×6 Slow Clap ×2

Posting this because I searched for it and got nothing useful.

Setup: 0.5mg, week 55, sulphur burps present but not ruining anything. I changed exactly one variable — TRIUMPH — and tracked it for 4 weeks.

Result: a difference, but a small one, and well inside what I would call noise if someone else posted it. So I am putting it here rather than presenting it as a finding. If two or three other people have done the same thing we might actually learn something.

Not medical advice, obviously. This is one person with a spreadsheet.

1,290 up / 194 down87% upvoted43 commentsid 3ktmfi23 Dec 2025

43 comments

20 in this archive, depth 5

best — the order this archive was captured in

u/plateau_patrol146 points·7 months ago

This is correct. Discontinuation arms show the regain reality.

replysharereportpermalink
u/tomas_kimani211 points·7 months ago

Phase 2 TRIUMPH looked amazing. Phase 3 trials are harder. Do not anchor on phase 2 readouts.

replysharereportpermalink
u/karl_fischer_kev70 points·7 months ago

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

replysharereportpermalink
u/prior_auth_painappeals98 points·7 months ago·edited

dropout handling matters, especially on GI-heavy populations

replysharereportpermalink
u/injection_site_iris58 points·7 months ago

STEP, SURMOUNT, SURPASS, SELECT, FLOW, TRIUMPH — read the appendix

replysharereportpermalink
u/sten_palacios56 points·7 months ago

Strongly agree. Phase 2 is investigational, not conclusive.

replysharereportpermalink
u/ines_castellanos130 points·7 months ago

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

replysharereportpermalink
u/forest_plot_fionaMOD68 points·7 months ago

This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.

replysharereportpermalink
load more comments (5) →
u/ms_fragmenter84 points·7 months ago·edited

Strongly agree. Phase 2 is investigational, not conclusive.

replysharereportpermalink
u/alcohol_aversion39 points·7 months ago

The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.

replysharereportpermalink
u/joaquin_trevino29 points·7 months ago

This is correct. Discontinuation arms show the regain reality.

replysharereportpermalink
u/yara_mensah32 points·7 months ago

SURMOUNT-4 discontinuation arm showed regain. That is the reality of a chronic disease treatment, not a failure.

replysharereportpermalink
u/sanne_laurent40 points·7 months ago

Mechanistically the bit that matters is TRIUMPH. It explains most of the early profile and a decent chunk of the outcome.

replysharereportpermalink
u/laila_almeidaOP23 points·7 months ago

Phase 2 TRIUMPH looked amazing. Phase 3 trials are harder. Do not anchor on phase 2 readouts.

replysharereportpermalink
u/ahmed_iyer13 points·7 months ago

Yeah, absolute numbers matter more than the press release.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.